Amox Cv

# amox cv ## Overview - **Classification**: Penicillin antibiotic (beta-lactam) with beta-lactamase inhibitor - **Mechanism**: Amoxicillin inhibits bacterial cell wall synthesis. Clavulanic acid protects amoxicillin from beta-lactamase enzymatic degradation. ## Primary Indications 1. **Acute Otitis Media (AOM)** - Bacterial ear infection 2. **Acute Bacterial Sinusitis** - Bacterial infection of nasal sinuses 3. **Community-Acquired Pneumonia (CAP)** - Lung infection 4. **Skin and Soft Tissue Infections** - Including animal/human bite wounds 5. **Urinary Tract Infections (UTI)** - Limited use for resistant cases ## Adult Dosing ### Standard Dosing **Acute Bacterial Sinusitis, CAP, Skin/Soft Tissue Infections** - **Dose**: **875 mg amoxicillin / 125 mg clavulanate** - **Frequency**: Every 12 hours - **Route**: Oral - **Duration**: 7-10 days (uncomplicated), up to 14 days (complicated) **Acute Otitis Media, less severe infections** - **Dose**: **500 mg amoxicillin / 125 mg clavulanate** - **Frequency**: Every 8 hours - **Route**: Oral - **Duration**: 7-10 days ### Dose Adjustments - **Renal Impairment**: - **CrCl >30 mL/min**: No adjustment needed. - **CrCl 10-30 mL/min**: 500 mg / 125 mg every 12 hours (or 875/125 mg tablets not recommended due to fixed ratio of clavulanate). - **CrCl <10 mL/min**: 500 mg / 125 mg every 24 hours (or 875/125 mg tablets not recommended). - **Hemodialysis**: 500 mg / 125 mg every 24 hours, with an additional dose during and at end of dialysis. - **Hepatic Impairment**: Use with caution; monitor liver function. Not recommended in severe hepatic impairment. - **Elderly Patients**: No specific adjustment based on age alone, but assess renal function. ## Pediatric Dosing ### Neonates (0-28 days) - Use not routinely recommended due to immature renal function and potential for higher clavulanate levels. - **Special Notes**: Consult infectious disease specialist if use considered. ### Infants (1-12 months) - For Otitis Media, Sinusitis, CAP: **45 mg/kg/day** (amoxicillin component) in two divided doses. - **Dose**: **22.5 mg/kg** (amoxicillin) - **Frequency**: Every 12 hours - **Maximum**: **600 mg** amoxicillin per dose (from 600 mg/42.9 mg per 5 mL suspension) - **Formulation**: Use 600 mg/42.9 mg per 5 mL suspension for better amoxicillin:clavulanate ratio. ### Children (1-12 years) - For Otitis Media, Sinusitis, CAP: **45 mg/kg/day** (amoxicillin component) in two divided doses, or **90 mg/kg/day** in two divided doses for more resistant infections (e.g., AOM in children post-antibiotic failure). - **Dose**: **22.5 mg/kg or 45 mg/kg** (amoxicillin) - **Frequency**: Every 12 hours - **Maximum**: **600 mg** amoxicillin per dose (from 600 mg/42.9 mg per 5 mL suspension) - **Formulation**: Use 600 mg/42.9 mg per 5 mL suspension. ### Adolescents (13-18 years) - Approach adult dosing. - **Dose**: **875 mg / 125 mg** - **Frequency**: Every 12 hours - **Maximum**: **875 mg** amoxicillin per dose. ## Safety Information ### Contraindications - **Absolute**: History of severe hypersensitivity reaction to beta-lactams (e.g., anaphylaxis to penicillin or cephalosporin). - **Absolute**: History of cholestatic jaundice/hepatic dysfunction associated with amoxicillin/clavulanate use. - **Absolute**: Infectious mononucleosis (high risk of rash). ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea - **Common (1-10%)**: Nausea, vomiting, rash, candidiasis (oral/vaginal) - **Serious but Rare**: Anaphylaxis, severe cutaneous adverse reactions (SCARs), Clostridium difficile-associated diarrhea (CDAD), cholestatic jaundice, hepatitis. ### Key Drug Interactions - **Warfarin**: Increased INR; monitor closely, adjust warfarin dose. - **Probenecid**: Increases and prolongs amoxicillin blood levels; generally not problematic but consider in renal impairment. - **Methotrexate**: Increased methotrexate toxicity; monitor closely. - **Oral Contraceptives**: May reduce efficacy of oral contraceptives (controversial, but advise backup method). ## Monitoring & Follow-up - **Before Treatment**: Assess allergy history, renal and hepatic function (if risk factors). - **During Treatment**: Monitor for signs of allergic reaction, diarrhea, secondary infections (e.g., oral thrush). - **Clinical Signs**: Watch for persistent fever, worsening symptoms, severe watery diarrhea, yellowing of skin/eyes. ## Clinical Pearls - 💡 **Tip 1**: Take with food to minimize GI upset (nausea, diarrhea). - 💡 **Tip 2**: Shake oral suspension well before each use and store in refrigerator. Discard after 10 days. - 💡 **Tip 3**: Counsel patients on potential for rash, especially with infectious mononucleosis. - 💡 **Tip 4**: Advise patients to complete the full course of treatment even if feeling better. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.